Perrigo Claims Reckitt's Bid To Block Generic Mucinex Is "Baseless"
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser's petition seeking to define specific bioequivalence standards for private-label versions of Mucinex OTC cough products, if followed, would push FDA to violate generic drug law, Perrigo argues